Cargando…
Inhibition of HIV-1 Replication in Human Monocyte-Derived Macrophages by Parasite Trypanosoma cruzi
BACKGROUND: Cells of monocyte/macrophage lineage are one of the major targets of HIV-1 infection and serve as reservoirs for viral persistence in vivo. These cells are also the target of the protozoa Trypanosoma cruzi, the causative agent of Chagas disease, being one of the most important endemic pr...
Autores principales: | Andreani, Guadalupe, Celentano, Ana M., Solana, María E., Cazorla, Silvia I., Malchiodi, Emilio L., Martínez Peralta, Liliana A., Dolcini, Guillermina L. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2788415/ https://www.ncbi.nlm.nih.gov/pubmed/20011521 http://dx.doi.org/10.1371/journal.pone.0008246 |
Ejemplares similares
-
Trypanosoma cruzi (Chagas' disease agent) reduces HIV-1 replication in human placenta
por: Dolcini, Guillermina Laura, et al.
Publicado: (2008) -
Activity of Estafietin and Analogues on Trypanosoma cruzi and Leishmania braziliensis
por: Sülsen, Valeria P., et al.
Publicado: (2019) -
Anti-Trypanosoma cruzi Activity of Extracts from Argentinean Asteraceae Species
por: Selener, Mariana G., et al.
Publicado: (2019) -
Cruzipain and Its Physiological Inhibitor, Chagasin, as a DNA-Based Therapeutic Vaccine Against Trypanosoma cruzi
por: Cerny, Natacha, et al.
Publicado: (2020) -
Trypanosoma cruzi 80 kDa prolyl oligopeptidase (Tc80) as a novel immunogen for Chagas disease vaccine
por: Bivona, Augusto E., et al.
Publicado: (2018)